11136301

Source:http://linkedlifedata.com/resource/pubmed/id/11136301

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004388, umls-concept:C0005823, umls-concept:C0006684, umls-concept:C0018810, umls-concept:C0030705, umls-concept:C0085580, umls-concept:C0205314, umls-concept:C0220821, umls-concept:C0378675, umls-concept:C0439841, umls-concept:C0542341, umls-concept:C0679622, umls-concept:C1280500, umls-concept:C1547135, umls-concept:C1547139, umls-concept:C1561560, umls-concept:C1561561
pubmed:issue	6
pubmed:dateCreated	2001-1-9
pubmed:abstractText	The aim of the present study was to evaluate the effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-10362193, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-10489102, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-1352253, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-1494104, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-1577044, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-1671089, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-1822833, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-1881002, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-2372658, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-2447647, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-2500393, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-2874900, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-2924067, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-3319645, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-536291, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-6657864, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-7637142, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-7648682, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-7888745, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-8220895, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-8450526, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-8505097, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-8569048, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-8569049, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-8596091, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-8641742, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-8674168, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-9010696, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-9067302, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-9222940, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-9673431, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-9700998, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-9786607, http://linkedlifedata.com/resource/pubmed/commentcorrection/11136301-9931170
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7503323
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/Dihydropyridines, http://linkedlifedata.com/resource/pubmed/chemical/cilnidipine
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0306-5251
pubmed:author	pubmed-author:KawanoYY, pubmed-author:MakinoYY, pubmed-author:MatsuokaHH, pubmed-author:MinamiJJ, pubmed-author:TakishitaSS
pubmed:issnType	Print
pubmed:volume	50
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	615-20
pubmed:dateRevised	2010-9-14
pubmed:meshHeading	pubmed-meshheading:11136301-Adult, pubmed-meshheading:11136301-Autonomic Nervous System, pubmed-meshheading:11136301-Blood Pressure, pubmed-meshheading:11136301-Blood Pressure Monitoring, Ambulatory, pubmed-meshheading:11136301-Calcium Channel Blockers, pubmed-meshheading:11136301-Dihydropyridines, pubmed-meshheading:11136301-Female, pubmed-meshheading:11136301-Heart Rate, pubmed-meshheading:11136301-Humans, pubmed-meshheading:11136301-Hypertension, pubmed-meshheading:11136301-Male, pubmed-meshheading:11136301-Middle Aged, pubmed-meshheading:11136301-Outcome Assessment (Health Care), pubmed-meshheading:11136301-Pressoreceptors
pubmed:year	2000
pubmed:articleTitle	Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension.
pubmed:affiliation	Division of Hypertension and Nephrology, National Cardiovascular, Center, Suita 565-0873, Osaka, Japan. j-minami@dokkyomed.ac.jp
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't